Top Markets
Coin of the day
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Clasificación en acciones #13241
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Precio por acción
$4.99
Capitalización bursátil
$508.03M
Cambio (1 día)
-2.48%
Cambio (1 año)
2.10%
País
TW
Comercio Ever Supreme Bio Technology Co., Ltd (6712)

Categoría

Historial de rendimiento por dividendo de Ever Supreme Bio Technology Co., Ltd (6712)
Rendimiento por dividendo (TTM) de Ever Supreme Bio Technology Co., Ltd (símbolo bursátil: 6712) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Ever Supreme Bio Technology Co., Ltd (6712) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH